Connect with us
This counterattack by Gotham comes weeks after Grifols has received accolades following the confirmation of the sale to Haier of its 20% stake in Shanghai Raas...
Ailin secures 1.5 million euros in its first financing round, surpassing initial expectations. Investors include a family office in the health sector, Business Angels, and healthcare-related...
Grifols explained that the Strategic Alliance and Share Purchase Agreement signed with Haier on December 29th, 2023, is “binding” and that both parties are contractually obliged...
One of the grant projects is a clinical trial to improve the prognosis of acute lymphoblastic leukemia in children under one year of age, the most...
Biogen reports a positive balance in 2023 with $9.8 billion in revenues, a 3% decrease. Q4 2023 sales were $2.4 billion, down 6% from the same...
Qube Research & Technologies increases its short position on Grifols to 1.23%, up from 1.19%, amid market volatility due to the conflict with Gotham City Research....
Regarding the priorities of the Spanish health and biotechnology industries, first is the implementation of new tools and technologies, followed by the promotion of the culture...
UrbanFisio raises one million euros in its latest investment round, with French insurance group IMA and individual investors joining as new partners. The funding aims for...
The current project will last two years and will be financed by the Next Generation funds managed by the Center for Technological Development and Innovation (Cdti)...
Wegovy stands as Novo Nordisk's big bet. This medicine was what placed the Danish multinational company as the most valuable company in Europe last September, surpassing...